Peter A. Jones

82.8k citations

352 papers · 61.5k indexed · 28 hit papers · h-index 112

Impact in

Cancer Research top 0.02%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
Molecular Biology top 0.01%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Genomics and Chromatin Dynamics
- Histone Deacetylase Inhibitors Research

Papers in

Cancer Research 65
- Cancer Genomics and Diagnostics 28
Molecular Biology 272
- Epigenetics and DNA Methylation 213
- Cancer-related gene regulation 87
- RNA modifications and cancer 68
- Genomics and Chromatin Dynamics 54

Co-authors: Stephen B. Baylin Gangning Liang Shirley M. Taylor Daiya Takai Gerda Egger Christine B. Yoo Daniel D. De Carvalho Ana M. Aparicio
Journals: Molecular and Cellular Biology (24 papers)Cancer Research (17 papers)Nucleic Acids Research (15 papers)Proceedings of the National Academy of Sciences (15 papers)Cell (11 papers)
Partner nations: United States United Kingdom Denmark

In The Last Decade

Peter A. Jones

348 papers receiving 59.9k citations

Hit Papers

15 papers align trajectories log scale

Epigenetic therapy in immune-oncology 2019 · 368 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Nature reviews. Cancer
2016 Nature Reviews Genetics
2016 Cold Spring Harbor Perspectives in Biology
2015 Cell
2014 Cancer Cell
2012 Nature Reviews Genetics
2011 Nature reviews. Cancer
2010 Nature Biotechnology
2009 Nature Reviews Genetics
2007 Journal of Cellular Physiology
2007 Cell
2007 Pediatric Research
2006 Cancer Cell
2006 Nature Reviews Drug Discovery
2004 Nature
2002 Nature Reviews Genetics
2002 Proceedings of the National Academy of Sciences
2001 Science
1999 Trends in Genetics
1999 Nucleic Acids Research
1995 PubMed
1994 New England Journal of Medicine
1991 Science
1990 Science
1990 PubMed
1983 Science
1980 Cell
1979 Cell

Peers

Countries citing papers authored by Peter A. Jones

Since Specialization

Citations

This map shows the geographic impact of Peter A. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Jones more than expected).

Fields of papers citing papers by Peter A. Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Jones. The network helps show where Peter A. Jones may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter A. Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter A. Jones Line = papers co-authored together Peter A. Jones links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Overlapping DNA methylation changes in enhancers in clonal cytopenia of undetermined significance and myelodysplastic neoplasm patients with <i>TET2</i>, <i>IDH2</i>, or <i>DNMT3A</i> mutations Haematologica ·Jean Andreau, Morten Tulstrup, Jakob Werner Hansen, Claudia Schöllkopf, Klas Raaschou‐Jensen, Andreas Due Ørskov, Bo Porse, Peter A. Jones, Joachim Weischenfeldt, Linn Gillberg, Kirsten Grønbæk	2025	1
2	Oral Vitamin C Supplementation Modulates Inflammatory Cytokines in Clonal Cytopenia of Undetermined Significance and Low-Risk Myeloid Malignancies: Results from EVI-2 Trial Blood ·کاوه محمدپور, Stine Ulrik Mikkelsen, D.C. Kooijman, Isabela das Virgens Smirdel, Alicja Mortensen, Zachary Madaj, Jakob S. Jespersen, Linn Gillberg, Jakob Werner Hansen, Mette Klarskov Andersen, Anique M. J. van Oudheusden, Marianne Tang Severinsen, Casey L. O’Connell, Jens Lykkesfeldt, Peter A. Jones, Kirsten Grønbæk	2024	1
3	A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS‐102 in irinotecan‐refractory metastatic colorectal cancer patients International Journal of Cancer ·Valerie Lee, Rose Parkinson, Marianna Zahurak, Leslie Cope, Andrea Cercek, Henk M.W. Verheul, Elske C. Gootjes, Heinz Josef Lenz, Syma Iqbal, Peter A. Jones, Stephen B. Baylin, Ernesto Villablanca O., Nita Ahuja, Irvington on Hudson, Nilofer S. Azad	2024	7
4	Conserved epigenetic hallmarks of T cell aging during immunity and malignancy Nature Aging ·Mi Tian, Andrew G. Soerens, Shanta Alli, Dimitri, Anoop Babu Vasandan, Zhaoming Wang, Vaiva Vezys, Shunsuke Kimura, Ilaria Iacobucci, Stephen B. Baylin, Peter A. Jones, K. KIM, Hong-Bo Jin, Harris Goldstein, Charles G. Mullighan, Caitlin C. Zebley, David Masopust, Ben Youngblood	2024	15
5	RNA mis-splicing drives viral mimicry response after DNMTi therapy in SETD2-mutant kidney cancer Cell Reports ·Hongtao Li, H. Josh Jang, Krizia Rohena-Rivera, Minmin Liu, Hemant Gujar, Sharson E Kurpius, Shuqing Zhao, Guiling Li, 英樹山谷, Daniel J. Weisenberger, Inderbir S. Gill, Peter A. Jones, Neil A. Bhowmick, Gangning Liang	2023	16
6	Activation of a Subset of Evolutionarily Young Transposable Elements and Innate Immunity Are Linked to Clinical Responses to 5-Azacytidine Cancer Research ·Hitoshi Ohtani, Andreas Due Ørskov, G. A. Kurkina, Linn Gillberg, Minmin Liu, Wanding Zhou, Johanna Ungerstedt, Eva Hellström‐Lindberg, Weili Sun, Gangning Liang, Peter A. Jones, Kirsten Grønbæk	2020	36
7	A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to Irinotecan Clinical Cancer Research ·Valerie Lee, Judy Wang, Marianna Zahurak, Elske C. Gootjes, Henk M.W. Verheul, Rose Parkinson, Zachary Kerner, Anup Sharma, Gary L. Rosner, Ana De Jesus‐Acosta, Daniel A. Laheru, Dung T. Le, Aram Oganesian, Oswaldo Chicaiza N., Thomas D. Brown, Peter A. Jones, Stephen B. Baylin, Nita Ahuja, Monica Vargas Solla	2018	39
8	Dual Inhibition of DNA and Histone Methyltransferases Increases Viral Mimicry in Ovarian Cancer Cells Cancer Research ·Minmin Liu, Stacey L. Thomas, M. -C. Cammaerts-Tricot, Wanding Zhou, Zachary Madaj, Hitoshi Ohtani, Stephen B. Baylin, Gangning Liang, Peter A. Jones	2018	85
9	Identifying aggressive prostate cancer foci using a DNA methylation classifier Genome biology ·Kamilla Mundbjerg, Sameer Chopra, Mehrdad Alemozaffar, Christopher E. Duymich, Ranjani Lakshminarasimhan, Peter W. Nichols, Manju Aron, Kimberly D. Siegmund, Osamu Ukimura, Monish Aron, Mariana C. Stern, Parkash S. Gill, John D. Carpten, Torben F. Ørntoft, Karina D. Sørensen, Daniel J. Weisenberger, Peter A. Jones, Vinay Duddalwar, Inderbir S. Gill, Gangning Liang	2017	43
10	Vitamin C increases viral mimicry induced by 5-aza-2′-deoxycytidine Proceedings of the National Academy of Sciences ·Minmin Liu, Hitoshi Ohtani, Wanding Zhou, Andreas Due Ørskov, Jessica Charlet, Yang W. Zhang, Hui Shen, Stephen B. Baylin, Gangning Liang, Kirsten Grønbæk, Peter A. Jones	2016	150
11	Identification of DNA Methylation–Independent Epigenetic Events Underlying Clear Cell Renal Cell Carcinoma Cancer Research ·Elinne Becket, Sameer Chopra, Christopher E. Duymich, 主余华, Jueng Soo You, Kurinji Pandiyan, Peter W. Nichols, Kimberly D. Siegmund, Jessica Charlet, Daniel J. Weisenberger, Peter A. Jones, Gangning Liang	2016	29
12	Pharmacokinetics and toxicity of the novel oral demethylating agent zebularine in laboratory and tumor bearing dogs Veterinary and Comparative Oncology ·Christopher M. Fulkerson, Deepika Dhawan, D. I. Jones, Víctor E. Márquez, Peter A. Jones, Zemin Wang, Ru Bai, James E. Klaunig, D. O'donoghue C. Brink, Patty L. Bonney, Deborah W. Knapp	2015	7
13	A Panel of Three Markers Hyper- and Hypomethylated in Urine Sediments Accurately Predicts Bladder Cancer Recurrence Clinical Cancer Research ·Sheng‐Fang Su, Andre Luis Abreu, Yoshitomo Chihara, Yvonne Tsai, Claudia Andreu‐Vieyra, Siamak Daneshmand, Eila C. Skinner, Peter A. Jones, Kimberly D. Siegmund, Gangning Liang	2014	75
14	Unique DNA Methylation Patterns Distinguish Noninvasive and Invasive Urothelial Cancers and Establish an Epigenetic Field Defect in Premalignant Tissue Cancer Research ·Erika M. Wolff, Yoshitomo Chihara, Fei Pan, Daniel J. Weisenberger, Kimberly D. Siegmund, Kokichi Sugano, Kiyotaka Kawashima, Peter W. Laird, Peter A. Jones, Gangning Liang	2010	144
15	DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation Molecular Cancer Therapeutics ·Tina Branscombe Miranda, Connie C. Cortez, Christine B. Yoo, Gangning Liang, Masanobu Abe, Theresa K. Kelly, Víctor E. Márquez, Peter A. Jones	2009	473
16	The Putative Tumor Suppressor microRNA-101 Modulates the Cancer Epigenome by Repressing the Polycomb Group Protein EZH2 Cancer Research ·Jeffrey M. Friedman, Gangning Liang, Chun-Chi Liu, Erika M. Wolff, Yvonne Tsai, Wei Ye, Xianghong Jasmine Zhou, Peter A. Jones	2009	307
17	Long-term Epigenetic Therapy with Oral Zebularine Has Minimal Side Effects and Prevents Intestinal Tumors in Mice Cancer Prevention Research ·Christine B. Yoo, Jody C. Chuang, Hyang‐Min Byun, Gerda Egger, Allen S. Yang, Louis Dubeau, Tiffany I. Long, Peter W. Laird, Víctor E. Márquez, Peter A. Jones	2008	70
18	Inhibition of Histone Deacetylation Does Not Block Resilencing of p16 after 5-Aza-2′-Deoxycytidine Treatment Cancer Research ·Gerda Egger, Ana M. Aparicio, Г. Н. Ясменко, Peter A. Jones	2007	54
19	Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival Proceedings of the National Academy of Sciences ·Gerda Egger, Shinwu Jeong, Г. Н. Ясменко, Connie C. Cortez, Tony W.H. Li, Yoshimasa Saito, Christine B. Yoo, Peter A. Jones, Gangning Liang	2006	166
20	Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to Tamoxifen Cancer Research ·Martin Widschwendter, Kimberly D. Siegmund, Hannes Müller, Heidi Fiegl, Christian Marth, Elisabeth Müller‐Holzner, Peter A. Jones, Peter W. Laird	2004	268

About Peter A. Jones

Peter A. Jones is a scholar working on Cancer Research, Molecular Biology, Genetics, Biotechnology and Pathology and Forensic Medicine, having authored 352 papers that have together received 61.5k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (213 papers), Cancer-related gene regulation (87 papers), RNA modifications and cancer (68 papers), Genomics and Chromatin Dynamics (54 papers), Bladder and Urothelial Cancer Treatments (30 papers), Cancer Genomics and Diagnostics (28 papers), Genetic Syndromes and Imprinting (25 papers) and Cancer-related Molecular Pathways (24 papers). The work is most often cited by research in Cancer Research (10.9k citations), Molecular Biology (48.9k citations), Genetics (8.9k citations), Oncology (8.3k citations) and Hematology (2.5k citations). Peter A. Jones has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include Stephen B. Baylin, Gangning Liang, Shirley M. Taylor, Daiya Takai, Gerda Egger, Christine B. Yoo, Daniel D. De Carvalho, Ana M. Aparicio, Keith D. Robertson and Felicidad A. Gonzales. Their work appears in journals such as Molecular and Cellular Biology, Cancer Research, Nucleic Acids Research, Proceedings of the National Academy of Sciences and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact